A new drug may be a major advance in the fight against heart disease.
Caduet is the first treatment to address multiple risk factors for cardiovascular disease. It combines two common medications -- Norvasc, a treatment for high blood pressure and Lipitor, a cholesterol-lowering therapy.
The new treatment may prove significant in the prevention of cardiovascular events, such as heart attacks, in people who have high blood pressure plus three or more other cardiovascular risk factors.
Numerous studies have indicated that managing multiple risk factors may help to significantly reduce a person's chance of suffering a cardiovascular incident.
For more information about this new treatment, watch the video.